Activation of nuclear receptor subfamily 1 group D members 1 and 2 (Nr1d1 and Nr1d2; also known as REV-ERBα and REV-ERBβ) reduces atherosclerotic plaques and improves adverse cardiac remodeling after MI (18–20). The gene discussed is NR1D1; the disease is myocardial infarction.